BR0211276A - Processo para propagação de vìrus - Google Patents

Processo para propagação de vìrus

Info

Publication number
BR0211276A
BR0211276A BR0211276-0A BR0211276A BR0211276A BR 0211276 A BR0211276 A BR 0211276A BR 0211276 A BR0211276 A BR 0211276A BR 0211276 A BR0211276 A BR 0211276A
Authority
BR
Brazil
Prior art keywords
virus propagation
poxvirus
virus
chordopoxvirus
grown
Prior art date
Application number
BR0211276-0A
Other languages
English (en)
Inventor
Paul Howley
Karl Heller
Ingmar Raethe
Original Assignee
Bavarian Nordic As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8160630&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0211276(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bavarian Nordic As filed Critical Bavarian Nordic As
Publication of BR0211276A publication Critical patent/BR0211276A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/065—Poxviridae, e.g. avipoxvirus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/065—Poxviridae, e.g. avipoxvirus
    • C07K14/07—Vaccinia virus; Variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

"PROCESSO PARA PROPAGAçãO DE VìRUS". A presente invenção refere-se a um processo para produção de poxvírus, especificamente "Chordopoxvírus", onde o poxvírus é cultivado a uma temperatura abaixo de 37<198>C. O processo conduz à propagação aumentada do vírus em temperatura diminuída.
BR0211276-0A 2001-07-18 2002-07-02 Processo para propagação de vìrus BR0211276A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101122 2001-07-18
PCT/EP2002/007280 WO2003008533A2 (en) 2001-07-18 2002-07-02 Method for virus propagation

Publications (1)

Publication Number Publication Date
BR0211276A true BR0211276A (pt) 2004-08-03

Family

ID=8160630

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0211276A BRPI0211276B1 (pt) 2001-07-18 2002-07-02 processo para propagação de vírus
BR0211276-0A BR0211276A (pt) 2001-07-18 2002-07-02 Processo para propagação de vìrus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BRPI0211276A BRPI0211276B1 (pt) 2001-07-18 2002-07-02 processo para propagação de vírus

Country Status (20)

Country Link
US (1) US6924137B2 (pt)
EP (1) EP1412486B1 (pt)
JP (2) JP4700907B2 (pt)
KR (1) KR100908377B1 (pt)
CN (1) CN100513560C (pt)
AU (1) AU2002314201B2 (pt)
BR (2) BRPI0211276B1 (pt)
CA (1) CA2450206C (pt)
DE (1) DE60223812T2 (pt)
DK (1) DK1412486T3 (pt)
EA (1) EA006628B1 (pt)
HK (1) HK1066245A1 (pt)
HU (1) HUP0400393A3 (pt)
IL (2) IL158927A0 (pt)
MX (1) MXPA04000326A (pt)
NO (1) NO339056B1 (pt)
NZ (1) NZ529914A (pt)
PL (1) PL205926B1 (pt)
UA (1) UA82466C2 (pt)
WO (1) WO2003008533A2 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7445924B2 (en) 2000-11-23 2008-11-04 Bavarian Nordic A/S Modified Vaccinia Ankara virus variant and cultivation method
NZ524661A (en) * 2000-11-23 2005-03-24 Bavarian Nordic As Modified vaccinia ankara virus variant
CA2494379C (en) * 2002-09-05 2012-11-06 Bavarian Nordic A/S Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
US8691502B2 (en) 2008-10-31 2014-04-08 Tremrx, Inc. T-cell vaccination with viral vectors via mechanical epidermal disruption
WO2014009433A1 (en) 2012-07-10 2014-01-16 Transgene Sa Mycobacterium resuscitation promoting factor for use as adjuvant
BR112015000530A2 (pt) 2012-07-10 2018-08-28 Transgene Sa vacina de antígeno micobacteriano.
SG11201605595YA (en) 2014-01-09 2016-08-30 Transgene Sa Fusion of heterooligomeric mycobacterial antigens
WO2016131945A1 (en) 2015-02-20 2016-08-25 Transgene Sa Combination product with autophagy modulator
FR3042121A1 (fr) 2015-10-08 2017-04-14 Jean-Marc Limacher Composition anti-tumorale
EP3452081A1 (en) 2016-05-04 2019-03-13 Transgene SA Combination therapy with cpg tlr9 ligand
GB2555892B (en) * 2016-07-12 2021-03-31 Emulate Inc Removing bubbles in a microfluidic device
US20190328869A1 (en) 2016-10-10 2019-10-31 Transgene Sa Immunotherapeutic product and mdsc modulator combination therapy
JP7334124B2 (ja) 2017-06-21 2023-08-28 トランジェーヌ 個別化ワクチン
EP3842065A1 (en) 2019-12-23 2021-06-30 Transgene Process for designing a recombinant poxvirus for a therapeutic vaccine
WO2023213763A1 (en) 2022-05-02 2023-11-09 Transgene Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab
WO2023213764A1 (en) 2022-05-02 2023-11-09 Transgene Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2384845A1 (fr) * 1976-08-05 1978-10-20 Anvar Vaccin contre la myxomatose et nouvelle souche virale utilisee
JPS60202827A (ja) * 1984-03-28 1985-10-14 Chibaken 弱毒痘そうワクチン株
CA1341245C (en) * 1988-01-12 2001-06-05 F. Hoffmann-La Roche Ag Recombinant vaccinia virus mva
DE4405841C1 (de) * 1994-02-23 1995-01-05 Mayr Anton Prof Dr Med Vet Dr Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US5616487A (en) * 1994-09-15 1997-04-01 Aastrom Biosciences, Inc. Stabilized retrovirus compositions
WO1997012032A1 (en) * 1995-09-27 1997-04-03 The Government Of The United States Of America, As Represented By The Department Of Health And Human Services Production of infectious respiratory syncytial virus from cloned nucleotide sequences
KR100894670B1 (ko) * 1996-07-15 2009-04-22 더 가번먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 에즈 레프리젠티드 바이 더 디파트먼트 오브 헬쓰 앤드 휴먼 서비시즈 클론닝된 뉴클레오타이드 서열로부터 약독화된 호흡기 세포융합 바이러스 백신의 생산
NZ524661A (en) * 2000-11-23 2005-03-24 Bavarian Nordic As Modified vaccinia ankara virus variant

Also Published As

Publication number Publication date
AU2002314201B2 (en) 2006-09-21
CA2450206A1 (en) 2003-01-30
DK1412486T3 (da) 2008-03-10
EA006628B1 (ru) 2006-02-24
HK1066245A1 (en) 2005-03-18
EA200400195A1 (ru) 2004-06-24
NO20040158L (no) 2004-01-13
US20040234950A1 (en) 2004-11-25
BRPI0211276B1 (pt) 2018-12-04
PL366897A1 (en) 2005-02-07
HUP0400393A3 (en) 2004-10-28
PL205926B1 (pl) 2010-06-30
JP2011078424A (ja) 2011-04-21
JP5154632B2 (ja) 2013-02-27
DE60223812T2 (de) 2008-11-13
DE60223812D1 (de) 2008-01-10
IL158927A0 (en) 2004-05-12
UA82466C2 (uk) 2008-04-25
EP1412486A2 (en) 2004-04-28
CN1533433A (zh) 2004-09-29
IL158927A (en) 2009-09-01
EP1412486B1 (en) 2007-11-28
NO339056B1 (no) 2016-11-07
NZ529914A (en) 2005-03-24
KR20040018474A (ko) 2004-03-03
US6924137B2 (en) 2005-08-02
KR100908377B1 (ko) 2009-07-20
WO2003008533A2 (en) 2003-01-30
CA2450206C (en) 2012-08-21
HUP0400393A2 (hu) 2004-07-28
JP2004535203A (ja) 2004-11-25
MXPA04000326A (es) 2005-03-07
WO2003008533A3 (en) 2004-01-08
CN100513560C (zh) 2009-07-15
JP4700907B2 (ja) 2011-06-15

Similar Documents

Publication Publication Date Title
BR0211276A (pt) Processo para propagação de vìrus
BR0309581A (pt) Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c
BR0305258A (pt) Inibidores de polimerase de ns5b de hcv
BR0313373B1 (pt) processo para fabricação contìnua de artigos descartáveis de vestir.
BR0309712A (pt) Processo para a preparação de carbonitrilas 7-substituìda-3-quinolina e 3-quinol-4-ona
EA200401398A1 (ru) Замещённые фенилацетамиды и их применение в качестве активаторов глюкокиназы
BR0212185A (pt) Compostos e métodos para a preparação de compostos
BR0111583A (pt) Sistema catalisador, uso do mesmo, e, processo para preparar poliolefinas
ES2182234T3 (es) Inhibidores de metaloproteasa.
BR0214870A (pt) 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituìdas e aplicação das mesmas
BRPI0312398B8 (pt) derivado de 1,3-difenilprop-2-en-1-ona substituído, processo de preparação de compostos, composição farmacêutica e utilização de pelo menos um derivado de 1,3-difenilprop-2-en-1-ona substituído
BR0302369A (pt) Conjunto de elementos para estruturas de montagem
TW200510333A (en) Benzimidazole compounds
BR0209984A (pt) Processo para a preparação de prostaglandinas e seus análogos
DK1562444T3 (da) Fremgangsmåde til formindskelse af acrylamidindholdet i varmebehandlede levnedsmidler
BR0311242A (pt) Processo para preparar modafinil
BRPI0415179A (pt) derivados de amida como ligandos de canal de ìon e composições farmacêuticas e métodos de empregar as mesmas
BR9913144B1 (pt) processo para polimerização de olefinas.
BR0316868A (pt) Processo para a produção de pró-medicamentos de nucleosìdeo-3&#39;
BR0215027A (pt) Derivados de 6-aminomorfinano, processo de preparação para o mesmo e sua aplicação
BRPI0416534A (pt) composições multiparticuladas com estabilidade melhorada
BR0301667B1 (pt) processo para a preparaÇço de polÍmeros em emulsço com pureza elevada.
DK1644389T3 (da) Pyrinidinforbindelser med phosphonatgrupper som antivirale nukleotidanaloger
BR0213481A (pt) Sondas
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: BAVARIAN NORDIC A/S (DK)

Free format text: ALTERADA A SEDE DO TITULAR CONFORME REQUERIDA ATRAVES DA PETICAO NO 055511/RJ DE 28/09/2004.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 04/12/2018, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 18A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2598 DE 20-10-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.